Latest News
Additional Positive Results in COVID-19 Clinical Trial Using Stem Cells Manufactured by Performance Cell Manufacturing
More patients have been treated in Sorrento Therapeutics’ COVID-19 FDA-approved clinical trial using stem cells manufactured by Performance Cell Manufacturing. In late 2020, Performance Cell Manufacturing was contracted to manufacture stem cells for an FDA-approved...
Performance Cell Manufacturing Scales Up Production of Stem Cells for COVID-19 FDA Approved Clinical Trials
Performance Cell Manufacturing (PCM), a contract development and manufacturing organization, recently manufactured and is providing stem cell doses for use in an FDA approved COVID-19 clinical trial. The clinical trial, which is being conducted by Sorrento...
Patients Treated in COVID-19 Clinical Trial Using Stem Cells Manufactured by Performance Cell Manufacturing
Sorrento Therapeutics (Nasdaq: SRNE, "Sorrento") announced positive results from the first patients treated in its COVID-19 clinical trial using stem cells licensed from and provided by Personalized Stem Cells, Inc. (PSC). The stem cell platform and FDA approval for...
Performance Cell Manufacturing Completes Stem Cell Manufacturing Contract for Knee Osteoarthritis Clinical Trial
Performance Cell Manufacturing (PCM) recently completed a stem cell manufacturing contract for an FDA approved stem cell clinical trial for knee osteoarthritis. Manufacturing for the trial included processing adipose tissue (lipoaspirate) from 38 patients to produce...
Performance Cell Manufacturing’s Facility Approved for Stem Cell Manufacturing by the California Department of Public Health
Performance Cell Manufacturing (PCM), a contract development manufacturing organization division of VetStem Biopharma, announced that the facility they utilize for cGMP cell production is approved by the California Department of Public Health, Food and Drug Branch for...
Performance Cell Manufacturing Announces Opening of Expanded cGMP Cell Manufacturing Facility
Performance Cell Manufacturing (PCM), a division of VetStem Biopharma, announced the opening of its expanded cGMP cell therapy manufacturing facility at its headquarters in Poway, California. PCM was born from VetStem’s 15 years of experience with cGMP compliant cell...